General Healthy(605186)
Search documents
健麾信息大宗交易成交277.25万元
Zheng Quan Shi Bao Wang· 2025-12-19 14:44
健麾信息12月19日大宗交易平台出现一笔成交,成交量12.80万股,成交金额277.25万元,大宗交易成交 价为21.66元,相对今日收盘价溢价8.95%。该笔交易的买方营业部为长江证券股份有限公司武汉光谷大 道证券营业部,卖方营业部为国金证券股份有限公司深圳分公司。 证券时报·数据宝统计显示,健麾信息今日收盘价为19.88元,上涨0.40%,日换手率为0.90%,成交额为 2411.76万元,全天主力资金净流出6.47万元,近5日该股累计上涨1.95%,近5日资金合计净流出714.77 万元。 据天眼查APP显示,上海健麾信息技术股份有限公司成立于2014年07月11日,注册资本13600万人民 币。(数据宝) 12月19日健麾信息大宗交易一览 | 成交量 | 成交金额 | 成交价 | 相对当日收盘折 | | | | --- | --- | --- | --- | --- | --- | | (万 | (万元) | 格 | 溢价(%) | 买方营业部 | 卖方营业部 | | 股) | | (元) | | | | | 12.80 | 277.25 | 21.66 | 8.95 | 长江证券股份有限公司武汉 | ...
健麾信息12月19日现1笔大宗交易 总成交金额277.25万元 溢价率为8.95%
Xin Lang Cai Jing· 2025-12-19 10:11
进一步统计,近3个月内该股累计发生1笔大宗交易,合计成交金额为277.25万元。该股近5个交易日累 计上涨1.95%,主力资金合计净流出543.2万元。 责任编辑:小浪快报 炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 12月19日,健麾信息收涨0.40%,收盘价为19.88元,发生1笔大宗交易,合计成交量12.8万股,成交金 额277.25万元。 第1笔成交价格为21.66元,成交12.80万股,成交金额277.25万元,溢价率为8.95%,买方营业部为长江 证券股份有限公司武汉光谷大道证券营业部,卖方营业部为国金证券股份有限公司深圳分公司。 ...
健麾信息前3季净利降73% A股募4.8亿IPO国信证券保荐
Zhong Guo Jing Ji Wang· 2025-11-25 07:17
| 经营活动产生的现金流 | 不适用 | 不适用 | -5.934.306.80 | 不适用 | | --- | --- | --- | --- | --- | | 量净额 | | | | | 健麾信息于2020年12月22日在上交所主板上市,发行股份数量为34,000,000股,发行价格为14.20 元/股,保荐机构(主承销商)为国信证券股份有限公司,保荐代表人为孙婕、陈振瑜。 健麾信息上市募集资金总额为482,800,000.00元,募集资金净额为435,211,872.28元,分别用于健麾 信息医药物流智能产业化项目、市场营销与客户服务网络升级项目、医药物流机器人实验室建设项目、 药房自动化升级研发项目自动化设备投放项目、补充流动资金项目。 中国经济网北京11月25日讯 健麾信息(605186.SH)日前发布2025年三季度报告。2025年前三季 度,该公司实现营业收入2.70亿元,同比增长38.55%;实现归属于上市公司股东的净利润845.21万元, 同比下降73.63%;实现归属于上市公司股东的扣除非经常性损益的净利润810.03万元,同比下降 57.54%;经营活动产生的现金流量净额为-593.4 ...
上海健麾信息技术股份有限公司2025年第一次临时股东大会决议公告
Shang Hai Zheng Quan Bao· 2025-11-21 19:47
Core Points - The company held its first extraordinary general meeting of shareholders in 2025 on November 21, 2025, at a designated location in Shanghai [2][3] - All resolutions presented at the meeting were approved without any objections [2][5] Meeting Details - The meeting utilized a combination of on-site and online voting methods [3] - The meeting was convened by the company's board of directors and presided over by Chairman Dai Jianwei [3] - The procedures for convening and conducting the meeting complied with the Company Law and the company's articles of association, ensuring its legality and validity [3][8] Attendance - All 8 serving directors attended the meeting [4] - All 3 serving supervisors were present [4] - The board secretary, Qiu Hong, and other senior executives also attended the meeting [4] Resolutions Reviewed - The following resolutions were passed: 1. Cancellation of the supervisory board and amendment of the articles of association [5] 2. Revision of the company's general meeting rules [5][6] 3. Revision of the board meeting rules [6] 4. Revision of the independent director work system [6] 5. Revision of the independent director allowance management measures [6] 6. Revision of the external investment management system [6] 7. Revision of the external guarantee management system [6] 8. Revision of the related party transaction management system [6] 9. Revision of the management system for the use of raised funds [6] 10. Approval for the company to apply for a comprehensive credit line from banks [7] Voting Results - Resolutions 1, 2, and 3 were special resolutions that received more than two-thirds of the valid voting rights held by attending shareholders or their representatives [7]
健麾信息(605186) - 上海健麾信息技术股份有限公司2025年第一次临时股东大会决议公告
2025-11-21 09:30
证券代码:605186 证券简称:健麾信息 公告编号:2025-043 上海健麾信息技术股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 54 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 68,557,722 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例(%) | 50.4100 | (四) 表决方式是否符合《公司法》及《公司章程》的规定,大会主持情况等。 1.本次股东大会采用现场投票和网络投票相结合的表决方式; 2.本次股东大会由公司董事会召集,现场会议由公司董事长戴建伟先生主持; 3.本次股东大会的召集和召开程序以及表决方式和表决程序符合《公司法》及《公 (一) 股东大会召开的时间:2025 年 11 月 21 日 (二) 股东大会召开的地点:上海市松江区中辰路 518 号 A 栋 ...
健麾信息(605186) - 君合律师事务所上海分所关于上海健麾信息技术股份有限公司2025年第一次临时股东大会的法律意见书
2025-11-21 09:16
中国上海石门一路 288 号兴业太古汇香港兴业中心一座 26 层 邮编:200041 电话:(86-21)5298 5488 传真:(86-21)5298 5492 junhesh@junhe.com 关于上海健麾信息技术股份有限公司 2025 年第一次临时股东大会的法律意见书 致:上海健麾信息技术股份有限公司 君合律师事务所上海分所(以下简称"本所")接受上海健麾信息技术股份有 限公司(以下简称"公司")的委托,根据《中华人民共和国公司法》(以下简称 "《公司法》")、《中华人民共和国证券法》(以下简称"《证券法》")、《上 市公司股东会规则》(以下简称"《股东会规则》")等法律、法规、规范性文件 (以下简称"法律、法规")及《上海健麾信息技术股份有限公司章程》(以下简 称"《公司章程》")的有关规定,按照律师行业公认的业务标准、道德规范和勤 勉尽责精神,就公司 2025 年第一次临时股东大会(以下简称"本次股东大会") 有关事宜出具本法律意见书。 为出具本法律意见书之目的,本所委派律师(以下简称"本所律师")对公司 提供的与本次股东大会有关的文件和事实进行了核查和验证。在本所律师对公司 提供的有关文件进行 ...
健麾信息(605186) - 上海健麾信息技术股份有限公司关于设立募集资金专户并签订募集资金专户存储三方监管协议的公告
2025-11-20 09:30
证券代码:605186 证券简称:健麾信息 公告编号:2025-042 上海健麾信息技术股份有限公司 关于设立募集资金专户并签订募集资金专户存储三方监管 协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 根据中国证券监督管理委员会(以下简称"中国证监会")出具的《关于核 准上海健麾信息技术股份有限公司首次公开发行股票的批复》(证监许 可 [2020]3211号),公司于 2020年 12月首次公开发行人民币普通股(A股) 34,000,000股。公司每股发行价格为人民币14.20元,本次募集资金总额为 人民币 482,800,000.00 元 , 扣 除 各 项 发 行 费 用 ( 不 含 增 值 税 ) 人民币 47,588,127.72元,实际募集资金净额为人民币435,211,872.28元。上述募集资金到 位情况已经立信会计师事务所(特殊普通合伙)于2020年12月17日出具的信会师 报字[2020]第ZA16027号《验资报告》审验确认。 二、《募集资金专户存储三方监管协议》的签订情况 ...
医疗耗材供应链SPD板块11月19日跌1.42%,艾隆科技领跌,主力资金净流出9904.65万元
Sou Hu Cai Jing· 2025-11-19 09:28
Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.42% on November 19, with Ailong Technology leading the drop [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Key stocks in the medical consumables supply chain SPD sector showed mixed performance, with Jianfa Zhixin rising by 3.19% to a closing price of 34.00, while several others, including Guoyao Yici and Jiuzhoutong, saw declines of 0.55% and 0.59% respectively [1] - The trading volume and turnover for Jianfa Zhixin were 180,800 hands and 620 million yuan, respectively [1] Capital Flow - The medical consumables supply chain SPD sector saw a net outflow of 99.05 million yuan from main funds, while retail investors contributed a net inflow of 74.72 million yuan [2] - Notable individual stock capital flows included Jianfa Zhixin with a net inflow of 70.39 million yuan from main funds, while Ailong Technology experienced a net outflow of 2.99 million yuan [3]
医疗耗材供应链SPD板块11月17日跌1.51%,开开实业领跌,主力资金净流出2.44亿元
Sou Hu Cai Jing· 2025-11-17 09:22
Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.51% on November 17, with the leading stock, Kaikai Industrial, falling significantly [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers in the SPD sector included: - Langma Information: closed at 14.57, up 1.75% with a trading volume of 69,100 shares and a turnover of 100 million yuan - Dashi Intelligent: closed at 3.04, up 1.00% with a trading volume of 527,100 shares and a turnover of 160 million yuan - Guoxin Health: closed at 10.05, up 0.60% with a trading volume of 103,900 shares and a turnover of 104 million yuan [1] - Major decliners included: - Kaikai Industrial: closed at 14.83, down 4.14% with a trading volume of 312,500 shares and a turnover of 463 million yuan - Jianfa Zhixin: closed at 34.76, down 3.44% with a trading volume of 137,400 shares and a turnover of 481 million yuan - Yingte Group: closed at 11.85, down 2.79% with a trading volume of 87,300 shares and a turnover of 104 million yuan [2] Capital Flow - The SPD sector saw a net outflow of 244 million yuan from institutional investors, while retail investors contributed a net inflow of 241 million yuan [2] - The detailed capital flow for selected stocks showed: - Guokai Hengtai: net inflow of 7.31 million yuan from institutional investors - Dashi Intelligent: net outflow of 8.11 million yuan from retail investors - Langma Information: net outflow of 1.80 million yuan from retail investors [3]
上海健麾信息技术股份有限公司关于更换持续督导保荐代表人的公告
Shang Hai Zheng Quan Bao· 2025-11-14 19:34
Core Points - The company has announced a change in its continuous supervision sponsor representative due to personal work changes of the previous representative [1][2] - The new sponsor representative, Liu Yaxin, will take over the duties from Chen Zhenyu, ensuring the continuity of supervision work [1][2] - The continuous supervision period is extended until the obligations set by the China Securities Regulatory Commission and the Shanghai Stock Exchange are fulfilled [2] Company Information - Liu Yaxin is a senior business director at Guosen Securities with a master's degree in clinical medicine and has been involved in investment banking since 2015 [4] - The company expresses gratitude to Chen Zhenyu for his contributions during his tenure as the sponsor representative [3]